New
HealthMore in Health→
Psilocybin-Assisted Therapy Shows Promise for Treatment-Resistant Depression in NHS Trial
Key Takeaways
- Randomized controlled trial in NHS England with 60 adults with treatment-resistant major depressive disorder.
- Psilocybin-assisted therapy led to significant reduction in depressive symptoms compared to placebo.
- No serious adverse events; safety profile acceptable.
- Findings suggest feasibility of psychedelic therapy in public healthcare settings.
DE
DT Editorial Team··via nature.com